In ovarian cancer patients, tumor-associated inflammatory mediator prostaglandin E2 (PGE2) induced the production of CXCL12(SDF1) in TME and functional expression of CXCR4 on MDSCs, which further attracted MDSCs into the TME [24]. Here, CXCL12 is linked to ovarian carcinoma.